Biodexa Pharmaceuticals PLC announced the activation of its first clinical study site for the Phase 3 Serenta trial, which aims to evaluate the efficacy and safety of eRapa in treating familial ...
Identification of High-Performing Safety Net Hospitals for Radical Cystectomy: Implications for National Cancer Institute Cancer Center Partnership Familial adenomatous polyposis (FAP) is an autosomal ...
Familial adenomatous polyposis (FAP) is an autosomal dominant disorder driven by germline mutations in the APC gene, leading to hundreds or thousands of colorectal adenomas and an almost inevitable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results